Preparation method of key intermediates of iribulin-like compounds

By using boric acid or borate ester catalysts and specific solvent systems, the problem of poor regioselectivity in the preparation of iribulin intermediates was solved, achieving an efficient and low-cost synthesis process that improves product purity and yield.

CN118027056BActive Publication Date: 2026-11-17HSING PHARMACEUTICALS CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202211358865.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-11-01
Publication Date
2026-11-17
Estimated Expiration
2042-11-01

AI Technical Summary

Technical Problem

In the existing technology for preparing eribulin intermediate compounds, there are problems such as poor regioselectivity, many by-products, low conversion rate and slow reaction rate, resulting in complicated process and high cost.

Method used

Boric acid or boronic acid esters are used as catalysts to react with p-toluenesulfonyl chloride under alkaline conditions to generate intermediate compounds. Purity and conversion are improved through specific solvents and post-treatment steps, including extraction, drying, concentration and purification.

Benefits of technology

It improved reaction conversion rate, reduced side reactions, simplified operation process, reduced production costs, and improved product purity and yield.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118027056B_ABST
    Figure CN118027056B_ABST
Patent Text Reader

Abstract

A method for preparing compound (10) from compound (9): the method uses boric acid or borate ester as a catalyst, and under alkaline conditions, reacts p-toluenesulfonyl chloride with compound (9) to generate compound (10), wherein the boric acid or borate ester has the following structural formula: The method of the present invention uses a trace amount of catalyst and replaces the reaction reagent, thereby reducing the occurrence of side reactions, improving the conversion rate of reactants, shortening the reaction time, and reducing the cumbersome operation of reactant recovery and reuse, thereby reducing the economic cost of the entire synthesis process.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to a method for preparing key intermediate compounds that can be used to prepare leptospirin analogs, particularly eribulin, and belongs to the field of organic synthesis technology. Background Technology

[0002] Halichondrin (HB) is a class of natural products with a polyether macrocyclic lactone structure found in corpora cavernosa. These substances have strong antitumor effects and broad pharmaceutical prospects. Eribulin (EB) is a structurally simplified analogue of halichondrin and is currently used clinically to treat advanced breast cancer and liposarcoma.

[0003]

[0004] Neither HB nor EB can be obtained in large quantities from natural sources and must be synthesized artificially. Eribulin has a complex structure, containing 19 chiral carbon atoms in its molecule. The currently used total synthetic route is as long as 62 steps, so the labor cost in production accounts for a very large proportion, and the yield becomes more and more critical to the cost in the later steps.

[0005] In the prior art, the reaction conditions for converting the intermediate compound (9) of eribulin into compound (11) are as follows: First, the primary hydroxyl group is selectively sulfonated using p-toluenesulfonic anhydride in the presence of a suitable base to generate compound (10); then, under the action of ammonia, compound (10) loses one molecule of methanesulfonic acid to generate an epoxy compound (14); finally, the epoxide ring is opened again by the nucleophilic addition reaction of NH3, thereby completing the synthesis of the target compound (11). However, in the actual reaction process, the regioselectivity of sulfonation under the above conditions is poor, and the generation of the C34 hydroxysulfonation byproduct compound (10a) cannot be avoided. This compound can first form an epoxy intermediate (14a) and further generate the C34 epimer (11a) of compound (11) (its content is basically above 3%), thus affecting the purity of the product. In addition, p-toluenesulfonic anhydride is a reagent with low reactivity, the reaction rate is slow, and the actual conversion rate is difficult to guarantee. Studies have shown that in the reactions of compounds (9) to (10) carried out according to the above method, the reaction is stopped when the conversion rate reaches ~60%. Extending the reaction time does not substantially improve the effect, thus necessitating the recovery of raw materials and repeated feeding, making the process cumbersome, involving many steps and repetitive operations. Therefore, this step of the reaction in the prior art deserves improvement to enhance the conversion rate and the regioselectivity of the reaction.

[0006] Summary of the Invention

[0007] This invention provides a method for preparing compound (10) from compound (9):

[0008] The method uses boric acid or borate ester as a catalyst to react p-toluenesulfonyl chloride with compound (9) under alkaline conditions to generate compound (10).

[0009]

[0010] The boric acid or borate ester has the following structural formula:

[0011]

[0012] Where R1 is R or OR, and R is hydrogen or C. 1-12 Halogenated alkyl, aryl substituted C 1-12 Alkyl or C 1-12 Alkyl group. Preferably, the C 1-12 Haloalkyl, C 1-12 Alkyl group preferred C 1-6 Alkyl, the aryl-substituted C 1-12 alkyl groups substituted with phenyl C 1-6 Alkyl groups, such as benzyl groups;

[0013] R2 and R3 are: C that can be arbitrarily replaced. 1-12 Alkyl or C 6-10 aryl, preferably C substituted by choice 1-6 Alkyl or phenyl;

[0014] R4 is H, and C is a replaceable form. 1-12 Alkyl groups, wherein the substituents are independently selected from C10. 1-6 Alkyl groups, halogens, OH, -NR a R b R a and R b Independently selected from H, C 1-6 alkyl.

[0015] As an example, the boric acid or borate ester is 2-aminoethyl biphenyl borate ester.

[0016] The base is selected from ammonia or an organic amine, wherein the organic amine is C. 1-8 Aliphatic amines, C 4-12 Alicyclic amines, C 4-12One or more of the aromatic amines. As examples, the organic amine is, for example, one or a mixture of several of the following: triethylamine, N-methylmorpholine, piperidine, N-methylpiperidine, N,N-diisopropylethylamine, 1,5-diazabicyclo[4.3.0]non-5-ene (DBN), 1,8-diazabicyclo[5.4.0]dec-7-ene (DBU), pyridine, 2,4,6-trimethylpyridine, and 4-dimethylaminopyridine (DMAP).

[0017] According to one embodiment of the present invention, the organic amine is selected from NR'3, and R' is selected from C. 1-6 alkyl.

[0018] According to one embodiment of the present invention, the reaction is carried out in a solvent selected from acetonitrile, dichloromethane, toluene, and tetrahydrofuran.

[0019] According to one embodiment of the present invention, the reaction is carried out at a temperature of 10-40°C, preferably 20-30°C.

[0020] According to one embodiment of the present invention, the amount of boric acid or borate ester is 1%-10% of the amount of compound (9), preferably 3%-5%.

[0021] The present invention also provides a method for preparing compound (11) from compound (9), the method comprising the steps of preparing compound (10) from compound (9) as described above.

[0022] According to one embodiment of the present invention, it further includes the step of concentrating and collecting the prepared compound (10).

[0023] According to one embodiment of the present invention, it further includes the step of preparing compound (11) from compound (10).

[0024] R1 is defined as described above.

[0025] According to one embodiment of the present invention, compound (11) is prepared by reacting compound (10) with ammonia at room temperature.

[0026] According to one embodiment of the present invention, the step of preparing compound (11) from compound (10) is carried out in a solvent, such as ethanol, isopropanol, or dichloromethane.

[0027] According to one embodiment of the present invention, the method further includes post-processing steps of extracting, drying, concentrating, and purifying the compound (11).

[0028] According to one embodiment of the present invention, the extraction step is as follows: the solvent of the reaction system is removed, and an aqueous solution of dichloromethane and sodium bicarbonate / sodium carbonate is used as the extractant to separate the organic phase.

[0029] The present invention also provides a method for preparing iribulin and leucocele B, the method comprising the steps of preparing compound (10) as described above. Further, it also includes the steps of preparing compound (11) as described above.

[0030] Beneficial effects:

[0031] This invention improves the method for preparing eribulin intermediates by using a trace amount of catalyst and replacing the reaction reagent with p-toluenesulfonic anhydride, thereby reducing side reactions, increasing reactant conversion, shortening reaction time, reducing the cumbersome operation of reactant recovery and reuse, and lowering the requirement for anhydrous reaction, thus reducing the economic cost of the entire synthesis process. The method of this invention is simple to operate and brings great convenience to industrial production. Attached Figure Description

[0032] Figure 1 HPLC chromatogram of the product from Example 2. Detailed Implementation

[0033] The preparation method and application of the present invention will be further described in detail below with reference to specific embodiments. It should be understood that the following embodiments are merely illustrative and explanatory of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are covered within the scope of protection intended by the present invention. Unless otherwise stated, the raw materials and reagents used in the following embodiments are commercially available products or can be prepared by known methods. Experimental methods not specifying specific conditions in the embodiments were performed according to conventional methods and conditions.

[0034] Example 1: Preparation of compound (10)

[0035] Compound (9) (19 g), 2-aminoethyl biphenyl borate ester (0.6 g), and N,N-diisopropylethylamine (7.3 mL) were dissolved in anhydrous acetonitrile (720 mL), and p-toluenesulfonyl chloride (7.3 g) was added. The mixture was reacted overnight at room temperature, and the starting material was observed to disappear via TLC. The reaction mixture was then concentrated to obtain crude compound (10), which was directly used in the next reaction without purification.

[0036] Example 2: Preparation of compound (11)

[0037] Isopropanol (1.57 L) and concentrated ammonia (1.93 L) were added to the crude compound (10) and reacted overnight at room temperature. The starting material disappeared as observed by TLC. The solvent was removed by vacuum distillation below 30 °C, and dichloromethane (1 L) and sodium bicarbonate / sodium carbonate / water (9 / 9 / 182) solution (360 mL) were added. The mixture was separated, and the aqueous phase was extracted three times with dichloromethane. The organic phases were combined, dried, concentrated, and column chromatography was performed to obtain compound (11) (17.4 g), with a yield of 91%. HPLC confirmed that the purity of compound 11 was 98.599%, and the content of compound 11a was only 0.012%. For details, please refer to the appendix. Figure 1 The peak at 8.501 minutes is compound 11a, and the peak at 8.911 minutes is compound 11.

[0038] Comparative Example 1: Preparation of Compound (10)

[0039] Compound (9) (2.6 g) was dissolved in dichloromethane (50 mL), and a dichloromethane solution (1 mL) of pyridine (14 mg) and 2,4,6-trimethylpyridine (1.7 g) was added. The reaction system was cooled to -10 °C, and p-toluenesulfonic anhydride (1.24 g) was added. The reaction was carried out for 1 hour. The starting material and product were detected by TLC. If there was a raw material remaining, p-toluenesulfonic anhydride (0.6 g) was added twice. After one hour, about 40% of the raw material was still remaining. Compound (10) generated in the reaction system was directly used for subsequent reactions.

[0040] Comparative Example 2: Preparation of Compound (11)

[0041] Add water (10 mL) to the above reaction system, raise to room temperature, add isopropanol (260 mL), and 25%–28% ammonia water (280 mL). React for 15 hours, and monitor the reaction of compound (10) and epoxy intermediate (14) by TLC to ensure complete reaction. Remove the solvent under reduced pressure below 30°C, add dichloromethane (160 mL), and sodium bicarbonate / sodium carbonate / water (9 / 9 / 182) solution (50 mL). Separate the mixture, extract the aqueous phase three times with dichloromethane, combine the organic phases, dry, concentrate, and precipitate by column chromatography to obtain compound (11) (1.4 g), with a yield of 54%. Recover compound (9) (1.02 g), accounting for 39% of the input.

[0042] The specific embodiments of the present invention have been described above by way of example. However, the scope of protection of the present invention is not limited to the above exemplary embodiments. Any modifications, equivalent substitutions, improvements, etc., made by those skilled in the art within the spirit and principles of the present invention should be included within the scope of protection of the claims of the present invention.

Claims

1. A method for preparing compound (10) from compound (9): The method uses 2-aminoethyl biphenyl borate ester as a catalyst to react p-toluenesulfonyl chloride with compound (9) under alkaline conditions to generate compound (10). , in, R1 stands for OR, and R stands for methyl.

2. The process according to claim 1, wherein the base is selected from an organic amine, which is one of an aliphatic amine, a 1-8 cycloaliphatic amine, and an aromatic amine. 4-12 cycloaliphatic amine, and an aromatic amine. 4-12 cycloaliphatic amine, and an aromatic amine.

3. The method according to claim 1, wherein the reaction is carried out in a solvent selected from acetonitrile, dichloromethane, toluene, and tetrahydrofuran.

4. The method according to claim 1, wherein the reaction is carried out at a temperature of 10-40°C.

5. The method according to claim 1, wherein the mass amount of the catalyst is 1%-10% of the mass amount of compound (9).

6. A method for preparing compound (11) from compound (9), said method comprising the method for preparing compound (10) from compound (9) according to any one of claims 1-5, and then preparing compound (11) from compound (10): 。 7. The method according to claim 6, further comprising the step of concentrating and collecting the prepared compound (10).

8. According to the method of claim 6, compound (11) is prepared by reacting compound (10) with ammonia at room temperature.

9. The method according to claim 6, wherein the step of preparing compound (11) from compound (10) is carried out in a solvent selected from ethanol, isopropanol, and dichloromethane.

10. The method according to claim 6 further includes post-processing steps of extracting, drying, concentrating, and purifying the compound (11).

11. The method according to claim 10, wherein the extraction step comprises: removing the solvent from the reaction system, using an aqueous solution of dichloromethane and sodium bicarbonate / sodium carbonate as the extractant, and separating the liquid to obtain the organic phase.

Citation Information

Patent Citations

  • Intermediate for preparing Eribulin and preparation method thereof

    CN109694379A

  • Process for the preparation of eribulin mesylate intermediate

    US20210040107A1